Financial Statements — NBTX
Balance Sheet
(in millions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 28.82 | 66.33 | 21.63 | 63.02 | 102.34 |
| Total Current Assets | 39.89 | 80.46 | 33.63 | 72.86 | 115.87 |
| Total Non-current Assets | 5.28 | 6.22 | 6.78 | 7.77 | 8.05 |
| Total Assets | 45.17 | 86.68 | 40.41 | 80.62 | 123.92 |
| Total Current Liabilities | 63.04 | 56.52 | 49.85 | 42.58 | 38.04 |
| Total Non-current Liabilities | 51.09 | 51.94 | 44.34 | 36.25 | 44.45 |
| Total Liabilities* | 114.13 | 108.46 | 94.19 | 78.83 | 82.48 |
| Retained Earnings | -- | (314.58) | (282.96) | (229.10) | -- |
| Total Stockholder Equity | (68.95) | (21.78) | (53.78) | 1.79 | 41.43 |
* Derived from reported values
Income Statement
(in millions EUR) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 26.64 | 9.29 | 3.29 | 1.33 | 1.32 |
| Research & Development | 14.53 | 21.99 | 17.81 | 16.61 | 15.51 |
| Selling, General & Admin | 11.29 | 10.82 | 10.86 | 9.64 | 10.18 |
| Total Operating Expenses | 25.83 | 32.94 | 28.66 | 27.21 | 31.10 |
| Operating Income | 0.81 | (23.65) | (25.37) | (25.88) | (29.78) |
| Interest Expense | 4.17 | 3.77 | 3.71 | 2.60 | 2.96 |
| Pretax Income* | (5.38) | (21.73) | (28.10) | (26.35) | (30.42) |
| Tax Provision | 0.01 | 0.14 | 0.00 | 0.01 | 0.00 |
| Net Income | (5.38) | (21.87) | (28.10) | (26.36) | (30.42) |
| Basic EPS | (0.11) | (0.46) | (0.80) | (0.76) | (0.88) |
| Diluted EPS | (0.11) | (0.46) | (0.80) | (0.76) | (0.88) |
* Derived from reported values
Cash Flow Statement
(in millions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | (17.41) | (5.84) | (17.27) | (17.52) | (15.07) |
| Investing Cash Flow | (0.16) | (0.50) | (0.33) | 0.05 | (0.05) |
| Financing Cash Flow | (2.83) | (2.65) | (2.14) | (3.51) | (1.70) |
